Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344330 · ClinicalTrials.gov registry record
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
A clinical trial, sponsored by Texas A&M University.
- Completed
- Registry status
- 108
- Enrollment target
NCT01344330: Completed study, sponsored by Texas A&M University.
NCT01344330 is a clinical trial that has completed, run by Texas A&M University. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01344330 has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
This research study will assess cruciferous vegetable intake in patients presenting for screening colonoscopy and correlate intake with histone status and histone deacetylace (HDAC) expression in tissue biopsy specimens and peripheral blood mononuclear cells (PBMCs). The investigators will also measure sulforaphane (SFN) metabolites in blood as a biomarker of cruciferous vegetable intake.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-12 |
What the finished NCT01344330 record still lists
NCT01344330 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01344330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01344330 about?
NCT01344330 is a clinical study titled "Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients". This research study will assess cruciferous vegetable intake in patients presenting for screening colonoscopy and correlate intake with histone status and histone deacetylace (HDAC) expression in tissue biopsy specimens and peripheral blood mononuclear cells (PBMCs). The investigators will also meas...
What is the current status of trial NCT01344330?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2012-01. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01344330?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia